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Abstract
Introduction: Recent epidemiological evidence suggests that alteration in calcium, phosphorous or magnesium metabolism may have direct car-
diovascular consequences. However, it is unknown whether variations in serum values of these minerals are in relationship with lipid profi le and 
adiposity as metabolic risk factors of cardiovascular events in premenopausal women independent of confounders. The aim of this study was to 
investigate the relationship between serum calcium, magnesium and phosphorous with lipid profi le in healthy premenopausal women.
Materials and methods: This study was performed on 82 reproductive age women aged 17-50 who were randomly selected from general popu-
lation of Tabriz, Iran. They were assigned into obese and none-obese groups. Weight and height for BMI calculation were measured using a calibra-
ted Seca scale and cotton ruler which was attached to the wall. Body composition was analyzed by bioelectrical impedance analysis (BIA). Serum 
magnesium, calcium and phosphorous were measured colorimetrically; fasting blood glucose (FBG) and serum lipids were assessed by enzymatic 
methods.
Results: Obese woman had signifi cantly lower serum magnesium (P = 0.035) and signifi cantly higher fasting blood glucose (P = 0.028), total chole-
sterol (P = 0.035), triglyceride (P = 0.019), low density lipoprotein (P=0.003) and parathyroid hormone concentrations (P = 0.031) compared to non 
obese women. In correlation coeffi  cient analysis, serum calcium concentrations had a positive weak relationship with total cholesterol (r = 0.267, P 
= 0.013) and triglyceride (r = 0.301, P = 0.005) concentrations in all participants; whereas in separate analysis of subjects as obese and non obese 
groups, these relationships lost their signifi cance. Serum phosphorous had a weak positive relationship with total cholesterol (r = 0.31, P = 0.002) 
and an inverse weak relationship with parathyroid hormone (r = - 0.32, P = 0.002). After adjusting for confounding variables by multiple regression 
analysis, the positive relationship between serum calcium, triglyceride, high density lipoprotein and low density lipoprotein cholesterol were signi-
fi cant.
Conclusion: Our results indicate that abnormality in serum calcium and phosphorous is signifi cantly correlated with serum lipids. Further studies 
are warranted for interpretation of these associations and understanding the underlying mechanisms.
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Introduction
Calcium as an essential regulator in many homeo-
static systems plays an important role in contro-
lling diverse biological process such as hormone 
secretion, intermediary metabolism, and bone 
structure (1-3). Recently it has been suggested that 
some of metabolic disorders, hypertension and 
cardiovascular disease are linked by common de-
fects in metabolism of some divalent cations such 
as calcium and magnesium (4,5). The positive rela-
tionship between serum calcium and cardiovascu-
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lar disease (6) metabolic syndrome (1) or myocardi-
al infarction (7) has been reported in previous stu-
dies. On a parallel note, several studies have repor-
ted an inverse relationship between serum ma-
gnesium concentrations and lipid profi le (8,9). Low 
serum magnesium is associated with cardiovascu-
lar events and metabolic syndrome (10). Although 
the exact mechanisms underlying these relation-
ships are not fully understood, potential mechani-
sms is the basic role of these cations in metabolic 
pathways (11). It can be concluded from the above 
introduction that serum calcium and magnesium 
are considered as good predictors of lipid abnor-
mality; however one important unanswered que-
stion is that whether this relationship can be hap-
pened in healthy normal individuals without cardi-
ovascular disease and other morbidities. Previous 
studies were carried out in diabetes (12), hypot-
hyroidism (13) or metabolic syndrome (1) and not 
in normal subjects; therefore the aim of this study 
is to investigate the relationship of serum calcium, 
magnesium and phosphorus with lipid profi le in 
healthy Iranian premenopausal women.
Methods and materials
Subjects
The study was conducted at Nutritional research 
center, Tabriz University of medical science 
between January and July 2008. Subjects were re-
cruited through advertisement with letters which 
were sent to randomly selected homes in eastern 
region of Tabriz city. These letters included infor-
mation about general inclusion criteria of the 
study. A total of 82 healthy volunteer women were 
participated in our study. Subjects were divided 
into obese (N = 40) and non obese (N = 42) groups 
based on their body mass index. The inclusion cri-
teria of study were 17-50 years of age, BMI 30-34.9 
kg/m2 for obese and 18.5-24.9 kg/m2 for non obe-
se group. The exclusion criteria included a history 
of hepatic or renal disease, cardiovascular disease, 
diabetes, hypertension, treatment with estrogen 
and contraceptives (OCP), loop diuretics or cortico-
steroids. Subjects in the two groups were pair mat-
ched for age. Matching limit for age was ± 3 years. 
The study protocol was approved by ethics com-
mittee at Tabriz University of medical sciences and 
all subjects gave their written informed consent to 
participate in this study.
Biochemical measurements
Venous blood samples were collected from all su-
bjects between 7 and 9 a.m. after an overnight fa-
sting in tubes without additives. These samples 
were centrifuged; the serum was obtained and 
stored at -70°C until the assay. Serum concentrati-
ons of calcium, magnesium and inorganic phosp-
hate were measured using standard colorimetric 
methods (kits from Darman- Kave Co., Esfahan, 
Iran; Ziest Chem Co., Tehran-Iran and Cheme En-
zyme Co., Tehran-Iran respectively). Serum parat-
hyroid hormone (PTH) was measured with ELISA 
(Bio source Europe S.A, Nivelles, Belgium). The sen-
sitivity of this test was 2 ng/L and means inter and 
intra assay coeffi  cients of variation (CV) were 7.1 
and 1.1% respectively (14). Serum 25-hydroxy vita-
min D was measured by Chemiluminescence Im-
muno Assay (DiaSorin Inc., Stillwater, MN, USA). 
Sensitivity of this test was 17.5 nmol/l and means 
inter and intra assay coeffi  cient of variation was 
13.2% and 10.5% respectively. We also categorized 
subjects into three groups according to their se-
rum calcium or phosphorous levels: groups with 
low, medium and high serum calcium or phospho-
rous levels.
Fasting blood glucose (FBG), total cholesterol (TC), 
triglyceride (TG) and high density lipoprotein cho-
lesterol (HDL-C) levels were analyzed using enzy-
matic colorimetric method. The TG level in all su-
bjects was lower than 4.52 mmol/L (400 mg/dL); 
therefore we used Friedwald formula for estimati-
on of Low Density Lipoprotein Cholesterol (LDL-C) 
concentrations based on serum TC, TG and HDL le-
vels (15). Mean inter and intra assay CV were 1.14, 
0.061 for TC; 1.60, 1.53 for TG and < 4 for HDL res-
pectively.
Anthropometric and dietary assessments
Weight was measured to the nearest 0.1 kg using a 
calibrated Seca scale (Itin Scale Co., Inc. Germany) 
while subjects had light clothes and no shoes. Hei-
ght was measured using a cotton ruler which was 
attached to wall. Body mass index was calculated 
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as weight (kg) / height (m) 2. Waist circumference 
(WC) was obtained by measuring the smallest area 
below the rib cage and above the ambilicus. Stan-
ding hip circumference (HC) was measured at the 
inter trochantric level (16) Waist to hip ratio (WHR) 
was obtained by dividing the mean WC by the 
mean HC. Each participant had a body compositi-
on analysis with Bioelectrical Impedance Analysis 
(BIA) method (Human-IM Plus; DS Dietosystem, 
Milan, Italy). Demographic characteristics of su-
bjects were determined using a screening questi-
onnaire to provide information on general perso-
nal characteristics, health status, medication hi-
story and a history of previous medical disease. To 
assure that there is no diff erence between dietary 
calcium, magnesium and vitamin D intake between 
obese and non obese subjects, a three day diet re-
cord was obtained from participants. Average dai-
ly nutrient intakes were calculated by Nutritionist 
Ш software (N-Squared analytical software com-
puting, Ore., USA). Intake of magnesium, calcium 
and vitamin D that are correlated with total energy 
intake was adjusted for total energy intake with re-
sidual method (17).
Statistical analysis
SPSS software (version 17, SPSS Inc., Chicago, IL, 
USA) was used for all analysis. The Kolmogorov-
Smirnov test was used to verify the hypothesis of 
normal distribution, followed by the independent 
Student’s-t test supposing normal distribution, 
and the Mann-Whitney U test was used, when the 
supposition of normal distribution was not accep-
ted. The association between serum calcium, ma-
gnesium and phosphorous with fasting blood glu-
cose and lipid profi le was examined by using the 
Pearson’s correlation test or by Spearman’s rank 
correlation test.
Since BMI, WHR, PTH and 25-hydroxy vitamin D in-
fl uence the calcium metabolism, the above menti-
oned association was reassessed by multiple re-
gression analysis with excluding the confounding 
eff ect of these variables. In addition, subjects were 
categorized by tertiles into three groups according 
to serum calcium or phosphorous concentrations: 
groups with low, medium and high serum calcium 
or phosphorous concentrations. Kruskal-Wallis test 
was used to analyze the diff erences in serum lipids 
among three groups with Bonferroni corrections 
for multiple comparisons (18). Continuous varia-
bles are expressed as mean ± SD if they had nor-
mal distribution or median and Interquartile range 
(Q1-Q3) if not. Age was presented as median and 
range (maximum-minimum). P values less than 
0.05 is considered signifi cant.
Results
Profi le of obese and non obese groups are shown 
in table 1. All general characteristics are signifi -
cantly diff erent between groups except for age 
and dietary intake of calcium, magnesium and vi-
tamin D. Comparison of biochemical parameters 
between obese and non obese women (table 2) 
shows that serum FBG, TC, TG, LDL-C and PTH con-
centrations is higher and serum magnesium is 
lower in obese group. There is no signifi cant diff e-
rence between serum calcium, phosphorous, 
HDL-C and 25-hydroxy vitamin D concentrations 
between groups. In correlation coeffi  cient analysis 
(table 3) serum calcium concentrations had a posi-
tive weak correlation with TC (r = 0.267, P = 0.013), 
TG (r = 0.301, P = 0.005), and 25-hydroxy vitamin D 
concentrations (r = 0.303, P = 0.034) in all partici-
pants; whereas in separate analysis of subjects as 
obese and non obese groups, these relationships 
were not signifi cant. Correlation coeffi  cient is also 
signifi cant for the inverse weak relationship 
between serum magnesium concentrations and 
BMI, weight, WC, fat mass and for positive relation-
ship between serum magnesium and fat free 
mass.
Serum phosphorous had a weak positive relation-
ship with total cholesterol (r = 0.310, P = 0.002) and 
a weak negative relationship with parathyroid hor-
mone (r = - 0.342, P = 0.002). After controlling for 
confounding variables in multiple regression anal-
ysis serum calcium had a positive relationship with 
TG, LDL-C and HDL-C (table 4).
Subjects with higher serum calcium concentrati-
ons had signifi cantly higher levels of TC, TG and 
LDL-C compared with the corresponding levels in 
the subjects with low and medium calcium con-
centrations (P = 0.028, 0.045 and 0.038 respective-
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Characteristic Obese (N = 42) Non obese (N = 40) P
Age (years) 30 (17-51) 31 (19-45) 0.474
Weight (kg) 81.07 ± 10.13 58.19 ± 6.40 <0.001
Height (m) 1.57 ± 0.05 1.60 ± 0.05 0.036
BMI (kg/m2) 32.95 ± 3.35 23.40 ± 4.12 <0.001
Fat mass (%) 41.64 ± 4.85 27.36 ± 5.34 <0.001
Fat free mass (%) 58.06 ± 5.21 72.64 ± 5.34 <0.001
WHR 0.81 ± 0.05 0.74 ± 0.05 <0.001
WC (cm) 95.75 ± 8.0 74.68 ± 6.97 <0.001
Dietary calcium intake (mg/d) 511.03 ± 222.5 546.14 ± 319.78 0.673
Dietary magnesium intake (mg/d) 89.29 ± 56.92 103.14 ± 75.81 0.492
Dietary vitamin D (IU/d) 43.61 ± 8.03 47.03 ± 16.13 0.210
BMI - body mass index; WHR - waist to hip ratio, WC - waist circumference.
Data are presented as mean ± SD or median ± IQR (Interquartile range).
TABLE 1. Characteristics of study participants
TABLE 2. Biochemical characteristics of study participants
Characteristics Obese (N = 42) Non obese (N = 40) P
FBG (mmol/L) 4.26 ± 0.82 3.96 ± 0.61 0.028
Calcium (mmol/L) 2.22 ± 0.18 2.20 ± 0.17 0.459
Phosphorous (mmol/L) 1.11 ± 0.24 1.10 ± 0.24 0.561
Magnesium (mmol/L) 0.87 ± 0.11 0.97 ± 0.27 0.035
TC (mmol/L) 4.20 ± 0.95 3.85 ± 0.55 0.035
Triglycerides (mmol/L) 0.93 ± 0.26 0.81 ± 0.18 0.019
LDL-C (mmol/L) 2.84 ± 0.73 2.44 ± 0.48 0.003
HDL-C (mmol/L) 0.99 ± 0.13 0.98 ± 0.17 0.998
25 hydroxy vitamin D (nmol/L) 40.26 ± 19.12 41.42 ± 25.52 0.861
PTH (ng/L) 83.25 ± 39.84 65.53 ± 32.92 0.031
FBG - fasting blood glucose; TC - total cholesterol; LDL-C - low density lipoprotein cholesterol; HDL-C - high density 
lipoprotein cholesterol; PTH - parathyroid hormone. Data are presented as mean ± SD or median ± IQR (Interquartile 
ranges).
ly; Table 5). Post- hoc analysis has revealed that the 
mean level of TC in high calcium group was higher 
than in low and medium calcium groups (P = 0.032 
and 0.026 respectively). TG and LDL-C in this group 
was also higher than low calcium group (P = 0.044 
and 0.024 respectively). In comparison of subjects 
classifi ed by serum phosphorous levels, subjects 
with higher levels of serum phosphorus had signi-
fi cantly higher fasting blood glucose and lower tri-
glycerides (P = 0.034, 0.049 respectively; Table 6). 
According to post-hoc analysis results, the diff eren-
ces between FBG and TG among groups, were si-
gnifi cant between medium and high phosphoro-
us groups (P= 0.002 and 0.025 respectively).
Discussion
This study demonstrates that serum calcium is po-
sitively associated with lipid profi le in premenopa-
usal women. This association remained signifi cant 
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TABLE 3. Correlation coeffi  cient (with P values in brackets) for serum calcium, magnesium, phosphorous in relation to lipid profi le and 
body composition in total participants
TABLE 5. Fasting blood glucose and serum lipids of study subjects base on blood calcium tertiles.
TABLE 4. Multiple regression analysis between serum calcium, fasting blood glucose and lipid profi le (adjusted for 25-hydroxy vita-







FBG (mmol/L) 0.08 (0.444) 0.03 (0.979) - 0.12 (0.242)
TC (mmol/L) 0.27 (0.013) -0.01 (0.991) 0.31 (0.002)
Triglycerides (mmol/L) 0.30 (0.005) 0.02 (0.864) 0.18 (0.078)
LDL-C (mmol/L) 0.24 (0.027) -0.04 (0.718) 0.21 (0.042)
HDL-C (mmol/L) 0.08 (0.481) 0.01 (0.946) 0.02 (0.828)
25 hydroxy vitamin D (nmol/L) 0.30 (0.034) 0.13 (0.377) -0.06 (0.661)
PTH (ng/L) -0.01 (0.898) -0.13 (0.235) -0.32 (0.002)
BMI (kg/m2) 0.06 (0.563) -0.27 (0.014) 0.09 (0.405)
Weight (kg) 0.11 (0.331) -0.25 (0.020) 0.17 (0.110)
WC (cm) 0.10 (0.377) -0.26 (0.015) 0.15 (0.151)
WHR 0.14 (0.197) -0.20 (0.067) -0.17 (0.093)
Fat Mass (%) 0.08 (0.486) -0.28 (0.008) 0.02 (0.822)
Fat Free Mass (%) -0.11 (0.312) 0.29 (0.006) -0.01 (0.894)
FBG - fasting blood glucose; TC - total cholesterol; LDL-C - low density lipoprotein cholesterol; HDL-C - high density lipoprotein 
cholesterol; PTH - parathyroid hormone; BMI – body mass index; WC – waist circumference; WHR - waist to hip ratio.
Characteristics Calcium β (P)
FBG (mmol/L) 0.258 (0.145)
TC (mmol/L) -0.786 (0.260)
Triglycerides (mmol/L) 0.448 (0.050)
HDL-C (mmol/L) 1.275 (0.049)
LDL-C (mmol/L) 0.460 (0.038)
FBG - fasting blood glucose; TC - total cholesterol; LDL-C - low density 












FBG (mmol/L) 3.95 ± 0.55 4.15 ± 0.82 4.19 ± 0.86 0.590
TC (mmol/L) 3.82 ± 0.50 3.81 ± 0.83 4.36 ± 0.90 0.028
Triglycerides (mmol/L) 0.77 ± 0.156 0.91 ± 0.23 0.92 ± 0.28 0.045
HDL-C (mmol/L) 0.99 ± 0.14 0.99 ± 0.18 1.01 ± 0.15 0.829
LDL-C (mmol/L) 2.46 ± 0.46 2.51 ± 0.45 2.92 ± 0.87 0.038
FBG - fasting blood glucose; TC - total cholesterol; LDL-C - low density lipoprotein cholesterol; HDL-C - high density lipoprotein 
cholesterol.
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after adjusting for potential confounders (BMI, 
WHR, PTH and 25-hydroxy vitamin D). Subjects 
with higher serum calcium levels had higher se-
rum TC, TG, and LDL-C. Since the menopausal sta-
tus has signifi cant infl uence in lipid and calcium 
metabolism (19,20), the study groups were selec-
ted from premenopausal women. The fi rst report 
of association between serum calcium and lipid 
profi le (TC, HDL-C) was in De Bacquer et al. (21) 
study; although, the eff ect of potential confoun-
ding variables was not regarded in this report. Lars 
Lind and colleagues (1) found positive relations 
between blood pressure, serum glucose and cho-
lesterol with serum calcium concentrations by in-
cluding only BMI, age and BUN as confounding va-
riables. In a cohort of males aged 50 serum calci-
um was also defi ned as an independent prospecti-
ve risk factor for myocardial infarction (7). There 
are several potential mechanisms that may explain 
the association of serum calcium and lipid profi le. 
The average concentrations of serum PTH in our 
study sample was 76.2 ± 39.01 ng/L, whereas the 
normal range for serum PTH concentrations is 10-
65 ng/L (22), this elevated PTH concentrations le-
ads to excessive calcium accumulation in cytosol, 
PTH induced calcium entry into cells inhibits mito-
chondrial oxidation and ATP production and ulti-
mately increasing intracellular calcium (23); Increa-
sed cytosolic calcium is responsible for disturban-
ce in lipid metabolism and inducing hyperlipide-
mia (24-28). Calcium ions are necessary for insulin 
production by islet cells of pancreas and increased 
intracellular calcium concentrations may also indu-
ce insulin resistance and lipid abnormality (29). 
High serum PTH level has also suppressive eff ect 
on the lipoprotein lipase activity (24). Abnormality 
of this enzyme may result in increased triglyceride, 
low density lipoprotein cholesterol and decreased 
high density lipoprotein cholesterol (23). These 
mechanisms can somewhat explain the relation-
ship between serum calcium and lipid profi le, 
however due to the case - control design of the 
study, we are not able to clarify the causal nature 
of these relationships.
Subjects with higher serum phosphorous levels 
had signifi cantly higher levels of triglyceride con-
centrations than their controls. Other anthropo-
metric or biochemical variables were not diff erent 
between serum phosphorous groups except in the 
case of PTH (In low, medium and high phosphoro-
us groups: 89.91 ± 43.03, 76.17 ± 39.16 and 63.88 ± 
31.45 ng/L respectively; P = 0.040). This fi nding is 
in consistent with other researchers work such as 
Dhingra R et al. (30) and Park W. et al. (31). The bio-
logical mechanisms of the phosphate and triglyce-
ride relationship are not fully understood. A possi-
ble mechanism which has been explained by Park 
W. (31) is that serum phosphate aff ect phospholi-
pids metabolism in the liver. Another mechanism 
is diminishing lipoprotein lipase activity due to hi-
gher parathyroid hormone concentrations which 
consequently leads to abnormal lipid metabolism 
(24).
Another observation of our study is the signifi cant 
diff erence between serum magnesium concentra-
tions between obese and non obese women. This 











FBG (mmol/L) 4.33 ± 0.75 3.93 ± 0.80 4.04 ± 0.61 0.034
TC (mmol/L) 3.73 ± 0.85 3.96 ± 0.56 4.29 ± 0.85 0.271
Triglycerides (mmol/L) 0.82 ± 0.22 0.88 ± 0.20 0.90 ± 0.27 0.049
HDL-C (mmol/L) 0.98 ± 0.14 0.99 ± 0.16 1.03 ± 0.16 0.629
LDL-C (mmol/L) 2.49 ± 0.46 2.57 ± 0.56 2.85 ± 0.82 0.099
high density lip FBG - fasting blood glucose; TC - total cholesterol; LDL-C - low density lipoprotein cholesterol; HDL-C - high 
density lipoprotein cholesterol.
TABLE 6. Fasting blood glucose and serum lipids of study subjects base on blood phosphorous tertiles.
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posed by this authors lower dietary magnesium 
intake in obese individuals may be the main rea-
son for magnesium defi ciency in obese group, 
however as shown in table 1 magnesium intake in 
obese and non obese groups was not signifi cantly 
diff erent; the link between obesity and magnesi-
um defi ciency can partially be explained by infl a-
mmatory markers. Rodriguez (32) and Hauner (33) 
found a strong relationship between low serum 
magnesium and high tumor necrosis factor α 
(TNF-α) in obese subjects. Guerrero (34) and Lai-
mer (35) in similar studies reported negative relati-
on between serum magnesium and C-reactive 
protein in obesity. Production of infl ammatory 
cytokines by adipose tissue is the cause of increa-
sed infl ammatory markers in obesity. Cytokines 
such as TNFα and Interleukine-6 (IL-6) are secreted 
by adipose tissue (36,37). The cause and eff ect re-
lationship between serum magnesium and infl am-
matory markers in obesity is poorly known. One 
possible mechanism is that infl ammatory factors 
especially tumor necrosis factors increase renal 
1-α-hydroxylase activity and 1,25-(OH)2 vitamin D 
(38). This active metabolite enhances renal calcium 
reabsorption and so higher magnesium urinary 
excretion (39). In addition, low serum magnesium 
can promote weight gain by increasing intracellu-
lar calcium (40). Increased calcium in adipocytes 
enhances lipogenesis (41). It also activates phosp-
hodiesterase 3B and decrease lipolysis (42).
Similarly elevated serum PTH concentrations in 
obese group of the present study which has also 
been reported previously by other investigations 
(42-44) can be attributed to elevation in calcium 
infl ux in to adipocytes due to elevation of 1,25-
(OH)2 vitamin D production by PTH; this can pro-
mote lipid storage in adipose tissue (44). Another 
possible cause of increased PTH in obese individu-
als is altered mineral metabolism; according to 
previous report of T. Anderson et al changed com-
plex binding of plasma calcium could lead to se-
condary increase of parathyroid hormone in obe-
sity (45).
Some potential limitations of our study are as fo-
llows: fi rst, only women and not men were enro-
lled in this study, therefore we cannot generalize 
the results to the total population, second, insulin 
resistance and infl ammatory cytokines were not 
evaluated, whereas these markers have physiolo-
gical relations with both mineral metabolism and 
lipid abnormalities, fi nally, an interventional study 
rather than case-control one could better explain 
the causal relationship between variables. Despite 
these limitations one important clinical considera-
tions of our study is that calcium and phosphorous 
levels should be controlled as risk factors of lipid 
abnormality and consequently metabolic syndro-
me or cardiovascular disease.
In conclusion, this study showed a signifi cant asso-
ciation between serum calcium and lipid profi le 
even after adjusting for potential confounders 
(BMI, WHR, serum PTH, serum 25-hydroxy vitamin 
D,) in a group of premenopausal women. Additio-
nal research is warranted to confi rm or possibly re-
ject the potential links between these variables 
and clarifying the underlying mechanisms.
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Koncentracija kalcija, magnezija, fosfora i lipidni status u serumu kod zdravih 
Iranki u reproduktivnoj dobi
Sažetak
Uvod: Noviji epidemiološki dokazi upućuju na zaključak da promjena metabolizma kalcija, fosfora ili magnezija može imati izravnih kardiova-
skularnih posljedica. Međutim, nepoznato je jesu li varijacije u koncentraciji tih minerala u serumu povezane s lipidnim statusom i pretilošću 
kao metaboličkim rizičnim čimbenicima od kardiovaskularnih događaja kod žena u reproduktivnoj dobi nezavisno o zbunjujućim čimbenicima. 
Cilj ovog istraživanja bio je istražiti povezanost između koncentracije kalcija, magnezija i fosfora u serumu i lipidnog statusa kod zdravih žena u 
reproduktivnoj dobi.
Materijali i metode: Ovo je istraživanje provedeno na 82 žene u reproduktivnoj dobi od 17-50 godina koje su nasumično odabrane iz populacije 
grada Tabriza u Iranu. Težina i visina ispitanica izmjerene su umjerenom Seca vagom i pamučnom mjernom trakom pričvršćenom na zid. Postotak 
masnog tkiva određen je metodom bioelektrične impendancije (engl. bioelectrical impedance analysis, BIA). Koncentracija magnezija, kalcija i fos-
fora u serumu određena je kolometrijskom metodom; koncentracije glukoze natašte (FBG) i lipida u serumu određene su enzimskim metodama.
Rezultati: Koncentracije magnezija u serumu bile su statistički značajno niže (P = 0,035), a koncentracije glukoze natašte (P = 0,028), ukupnog 
kolesterola (P = 0,035), triglicerida (P = 0,019), lipoproteina niske gustoće (P = 0,003) i paratiroidnog hormona (P = 0,031) više kod pretilih 
ispitanica u usporedbi s ispitanicama s normalnom tjelesnom težinom. Koncentracije kalcija u serumu bile su u slaboj pozitivnoj korelaciji s kon-
centracijama ukupnog kolesterola (r = 0,267, P = 0,013) i triglicerida (r = 0,301, P = 0,005) kod svih ispitanica; dok je u podskupinama prema 
statusu pretilosti korelacija izgubila statističku značajnost. Koncentracija fosfora u serumu bila je u slaboj pozitivnoj korelaciji s koncentracijom 
ukupnog kolesterola (r = 0,31, P = 0,002) i inverznoj slaboj korelaciji s koncentracijom paratiroidnog hormona (r = - 0,32, P = 0,002). Višestruka 
regresijska analiza, nakon prilagodbe zbunjujućih čimbenika, pokazala je značajnu pozitivnu povezanost između koncentracije kalcija, trigliceri-
da, lipoproteina visoke gustoće i lipoproteina niske gustoće.
Zaključak: Naši rezultati upućuju na zaključak da su patološke vrijednosti koncentracije kalcija i fosfora u serumu u značajnoj korelaciji s koncen-
tracijom lipida u serumu. Potrebna su daljnja istraživanja kako bi se objasnila ta povezanost i razumjeli mehanizmi koji leže u podlozi.
Ključne riječi: kalcij; fosfor; magnezij; pretilost; postotak masnog tkiva; lipidni status 
